Donehower et al. carried out an analysis of TP53 mutations in 32 cancer types and 10,225 patients from The Cancer Genome Atlas (TCGA) and found that more than 91% of cancers with TP53 mutations show bi-allelic loss of functional TP53 [47]. The gene discussed is TP53; the disease is cancer.